Catálogo de publicaciones - revistas
Annual Review of Pathology: Mechanisms of Disease
Resumen/Descripción – provisto por la editorial en inglés
The Annual Review of Pathology: Mechanisms of Disease, in publication since 2006, covers significant advances in our understanding of the initiation and progression of important human diseases. Emphasis is placed on current and evolving concepts of disease pathogenesis, molecular genetic and morphologic alterations associated with diseases, and clinical significance.Palabras clave – provistas por la editorial
No disponibles.
Disponibilidad
Institución detectada | Período | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No detectada | desde mar. 2006 / hasta dic. 2023 | Annual Reviews |
Información
Tipo de recurso:
revistas
ISSN impreso
1553-4006
ISSN electrónico
1553-4014
Editor responsable
Annual Reviews Inc.
País de edición
Estados Unidos
Fecha de publicación
2006-
Cobertura temática
Tabla de contenidos
The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
Boris C. Bastian
Palabras clave: Pathology and Forensic Medicine.
Pp. 239-271
The Immune Response in Multiple Sclerosis
Sofía Rodríguez Murúa; Mauricio F. Farez; Francisco J. Quintana
<jats:p> Multiple sclerosis (MS) is a chronic autoimmune, inflammatory, and neurodegenerative disease that affects the central nervous system (CNS). MS is characterized by immune dysregulation, which results in the infiltration of the CNS by immune cells, triggering demyelination, axonal damage, and neurodegeneration. Although the exact causes of MS are not fully understood, genetic and environmental factors are thought to control MS onset and progression. In this article, we review the main immunological mechanisms involved in MS pathogenesis. </jats:p>
Palabras clave: Pathology and Forensic Medicine.
Pp. 121-139
DNA Methylation Profiling: An Emerging Paradigm for Cancer Diagnosis
Antonios Papanicolau-Sengos; Kenneth Aldape
<jats:p> Histomorphology has been a mainstay of cancer diagnosis in anatomic pathology for many years. DNA methylation profiling is an additional emerging tool that will serve as an adjunct to increase accuracy of pathological diagnosis. Genome-wide interrogation of DNA methylation signatures, in conjunction with machine learning methods, has allowed for the creation of clinical-grade classifiers, most prominently in central nervous system and soft tissue tumors. Tumor DNA methylation profiling has led to the identification of new entities and the consolidation of morphologically disparate cancers into biologically coherent entities, and it will progressively become mainstream in the future. In addition, DNA methylation patterns in circulating tumor DNA hold great promise for minimally invasive cancer detection and classification. Despite practical challenges that accompany any new technology, methylation profiling is here to stay and will become increasingly utilized as a cancer diagnostic tool across a range of tumor types. </jats:p>
Palabras clave: Pathology and Forensic Medicine.
Pp. 295-321